References
1
Dömling A.
Ugi I.
Angew. Chem. Int. Ed.
2000,
39:
3168
2
Weber L.
Curr. Med. Chem.
2002,
9:
1241
3
Schreiber S.-L.
Science
2000,
287:
1964
4
Dömling A.
Curr. Opin. Chem. Biol.
2000,
4:
318
5
Ugi I.
Werner B.
Dömling A.
Molecules
2003,
8:
53
6
Weber L.
Drug Discovery Today
2002,
7:
143
7a Ugi I, and Steinbrückner C. inventors; DE-B 1,103,337.
7b
Ugi I.
Steinbrückner C.
Chem. Ber.
1961,
94:
734
7c
Ugi I.
Dömling A.
Hörl W.
Endeavour
1994,
18:
115
8
Zhang JD.
Jacobson A.
Rusche JR.
Herlihy W.
J. Org. Chem.
1999,
64:
1074
Reviews:
9a
Orru RVA.
de Greef M.
Synthesis
2003,
1471
9b
Maracaccini S.
Torroba T.
Org. Prep. Proc. Int.
1993,
25:
141
9c
Armstrong RW.
Combs AP.
Tempest P.
Brown SD.
Keating TA.
Acc. Chem. Res.
1996,
29:
123
9d
Bienaymé H.
Hulme C.
Oddon G.
Schmitt P.
Chem.-Eur. J.
2000,
6:
3321
10
Janvier P.
Bienaymé H.
Zhu J.
Angew. Chem. Int. Ed.
2002,
41:
4291
11
General Procedure: To a stirred suspension of the amino acid amide hydrochloride 1 (2 mmol) and aldehyde 2 (2 mmol) in MeOH (4mL) and Et3N (2 mmol) was added. After 15 min the isocyanide 3 (2 mmol) and glacial acetic acid (2 mmol) were given to the reaction mixture. The solution was stirred overnight, the solvent was removed under reduced pressure and the residue was purified by preparative HPLC (H2O/MeOH gradient).
12 Spectral data for compound 4a: 1H NMR (400 MHz, CD3OD): δ = 2.73 (s, 3 H, CH3), 3.50 and 3.60 (AB, 2 H, 2
J
A,B = 17.6 Hz, CH2CN), 4.36 (s, 1 H, CH), 7.31-7.44 (m, 5 H, Ar-H’s). 13C NMR (100 MHz, CD3OD, DEPT, HSQC): δ = 26.34 (CH3), 35.70 (CH2CN), 66.98 (CH), 118.81 (CN), 128.85 and 129.86 (Ar-C-o,m), 129.54 (Ar-C-p), 139.17 (Ar-C-ipso), 174.25 (CONHCH3). ESI-MS: C11H13N3O (203.24) m/z = 204.1 [M + H]+, 226.1 [M + Na]+.
13 Spectral data for compound 4b: 1H NMR (400 MHz, DMSO-d
6): δ = 3.46 and 3.58 (AB, 2 H, 2
J = 14.8 Hz, CH2Ph), 3.43 and 3.67 (AB of ABX, 2 H, 2
J
A,B = 15.4 Hz, 3
J
A,X = 6.0 Hz, 3
J
B,X = 6.0 Hz, CH2CN), 7.12-7.45 (m, 10 H, Ar-H’s), 8.67 (X of ABX, 1 H, 3
J
A,X;B,X = 6.0 Hz, NHCH2CN). 13C NMR (100 MHz, DMSO-d
6, DEPT, gHSQC): δ = 35.56 (CH2Ph), 42.77 (CH2CN), 65.58 (CH), 119.34 (CN), 127.41 and 128.46 (Ar-C-p), 127.74, 128.18, 128.87, 129.01 (Ar-C-o,m), 139.37 and 139.92 (Ar-C-ipso), 171.36 (CO). ESI-MS: C17H17N3O (279.34) m/z = 280.2 [M + H]+, 302.1 [M + Na]+.
14 Spectral data for compound 4u′ (minor diastereoisomer, S,S-configuration): [α]D -44.6 (c 1.0 CHCl3). 1H NMR (400 MHz, CDCl3): δ = 2.03 (broad s, 1 H, NH), 2.32 (s, 3 H, CH3), 2.51 (d, 3 H, 3
J = 4.6 Hz, NHCH3), 2.94 and 3.14 (AB of ABX, 2 H, 2
J
A,B = 13.6 Hz, 3
J
A,X = 4.9 Hz, 3
J
B,X = 8.9 Hz, CHCH2Ph), 3.67 (X of ABX, 1 H, CHCH2Ph), 4.38 (s, 1 H, CH), 6.17 (broad s, 1 H, NH), 7.12-7.41 (m, 9 H, Ar-H’s). 13C NMR (100 MHz, CDCl3): δ = 21.08 (CH3), 25.92 (CONHCH3), 39.89 (CH2), 50.67 (CHCN), 65.24 (CHCONH), 119.46 (CN), 127.09 (Ar-C), 127.64 (Ar-C), 128.79 (Ar-C), 129.43 (Ar-C), 129.65 (Ar-C), 134.90 (Ar-C), 135.37 and 138.49 (Ar-C-ipso), 170.96 (CO). IR(solid): 2221 (CN) cm-1. ESI-MS: C19H21N3O (307.40) m/z = 308.1 [M + H]+, 330.0 [M + Na]+.
15 Spectral data for compound 4y: 1H NMR (400 MHz, CD3OD): δ = 0.93 (d, 3 H, 3
J = 7.2 Hz, CH3), 0.97 (d, 3 H, 3
J = 6.8 Hz, CH3), 1.90-1.99 (m, 1 H, CH), 3.02 (d, 1 H, 3
J = 5.2 Hz, CH), 3.43 and 3.67 (AB, 2 H, 2
J
A,B = 17.2 Hz, CH2CN), 4.39 (s, 2 H, CH2Ph), 7.22-7.32 (m, 5 H, Ar-H’s). 13C NMR (100 MHz, CD3OD, DEPT, HSQC): δ = 17.46 (CH3), 18.59 (CH3), 31.62 [CH(CH3)2], 35.65 (CH2CN), 42.84 (CH2Ph), 67.56 (CH), 118.06 (CN), 127.13 (Ar-C-p), 127.64 and 128.38 (Ar-C-o,m), 138.81 (Ar-C-ipso), 173.97 (CONHCH3). ESI-MS: C14H19N3O (245.32) m/z = 246.2 [M + H]+, 268.2 [M + Na]+.
16a X-ray single crystal structure determination of compound 4u′. Crystal data: C19H21N3O, M
r = 307.39, colorless crystal, 0.46 × 0.61 × 0.79 mm3, orthorhombic, space group P212121 (No. 19), a = 6.1962(1), b = 11.8249(1), c = 22.9857(2) Å, V = 1684.15(3) Å3, Z = 4, ρcalcd = 1.212 g cm-3, F(000) = 656, µ
(Mo-K
α) = 0.077 mm-1, T = 173 K. Data collection: Nonius MACH3 κ-axis CCD-diffractometer, Mo-Kα radiation (λ = 0.71073 Å), unit cell parameters by least-squares for 1827 reflections. A total of 29452 reflections were integrated
[16b]
and scaled.
[16c]
After merging (R
int = 0.029) 3076 [2974: I
o>2σ(I
o)] independent reflections remained and all were used to refine 292 parameters. Structure solution and refinement: The structure was solved by a combination of direct methods
[16d]
and difference-Fourier syntheses.
[16e]
All non-hydrogen atoms were refined with anisotropic displacement parameters. All hydrogen atoms were found and refined with individual isotropic displacement parameters. Full-matrix least-squares refinements were carried out by minimizing Σw(F
o
2-F
c
2)
[2]
and converged with R1 = 0.0273 [I
o>2σ(I
o)], wR2 = 0.0686 [all data], GOF = 1.084 and shift/error <0.001. As indicated by Flack’s parameter ε = 0.3(11) the correct enantiomer could not be assigned reliably by diffraction methods. Thermal ellipsoids the ORTEP-style representation of the molecular structures of compound 4u′ in the solid state are drawn are at the 50% probability level.
[16f]
Crystallographic data (excluding structure factors) for the structure reported in this paper have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication no. CCDC-223310 (4u′). Copies of the data can be obtained free of charge on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK [Fax: (internat.) +44(1223)336033; e-mail: deposit@ccdc.cam.ac.uk].
16b Data Collection Software for Nonius KappaCCD, Delft, The Netherlands, 2001.
16c
Otwinowski Z.
Minor W.
Methods Enzymol.
1997,
276:
307
16d
Altomare A.
Cascarano G.
Giacovazzo C.
Guagliardi A.
Burla MC.
Polidori G.
Camalli M.
J. Appl. Crystallogr.
1994,
27:
435
16e
Sheldrick GM.
SHELXL-97
University of Göttingen;
Göttingen, Germany:
1998.
16f
Spek AL.
‘Platon’: A Multipurpose Crystallographic Tool
Utrecht University;
Utrecht, The Netherlands:
2001.
17a
Klingler O.
Matter H.
Schudok M.
Bajaj SP.
Czech J.
Lorenz M.
Nestler HP.
Schreuder H.
Wildgoose P.
Bioorg. Med. Chem. Lett.
2003,
13:
1463
17b TOTU: O-[(Ethoxycarbonyl)-cyanmethylenamino]-N,N,N′,N′-tetramethyluronium-tetrafluoroborat: König W.
Proc. Eur. Pept. Symp. 21st
Leiden;
Netherlands:
1991.
p.143